(Q39568001)

13 September 2017

Hematopoietic gene therapy restores thymidine phosphorylase activity in a cell culture and a murine model of MNGIE. (English)

1 reference

13 September 2017

0 references

1 reference

J Torres-Torronteras

1

1 reference

13 September 2017

A Gómez

2

1 reference

13 September 2017

H Eixarch

3

1 reference

13 September 2017

L Palenzuela

4

1 reference

13 September 2017

G Pizzorno

5

1 reference

13 September 2017

M Hirano

6

1 reference

13 September 2017

A L Andreu

7

1 reference

13 September 2017

J Barquinero

8

1 reference

13 September 2017

R Martí

9

1 reference

13 September 2017

31 March 2011

1 reference

13 September 2017

1 reference

13 September 2017

18

1 reference

13 September 2017

8

1 reference

13 September 2017

795-806

1 reference

https://scigraph.springernature.com/pub.10.1038/gt.2011.24

13 September 2017

0 references

cites work

Thymidine phosphorylase gene mutations in MNGIE, a human mitochondrial disorder

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.24

Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE): a disease of two genomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.24

Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE): biochemical features and therapeutic approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.24

Allogeneic hematopoietic SCT as treatment option for patients with mitochondrial neurogastrointestinal encephalomyopathy (MNGIE): a consensus conference proposal for a standardized approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.24

Catabolism of thymidine in human blood platelets purification and properties of thymidine phosphorylase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.24

Elevated plasma deoxyuridine in patients with thymidine phosphorylase deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.24

Altered thymidine metabolism due to defects of thymidine phosphorylase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.24

Thymidine and deoxyuridine accumulate in tissues of patients with mitochondrial neurogastrointestinal encephalomyopathy (MNGIE)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.24

Mitochondrial deoxynucleotide pools in quiescent fibroblasts: a possible model for mitochondrial neurogastrointestinal encephalomyopathy (MNGIE).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.24

Unbalanced deoxynucleotide pools cause mitochondrial DNA instability in thymidine phosphorylase-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.24

Assessment of stability, toxicity and immunogenicity of new polymeric nanoreactors for use in enzyme replacement therapy of MNGIE.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.24

Allogeneic stem cell transplantation corrects biochemical derangements in MNGIE

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.24

Carrier erythrocyte entrapped thymidine phosphorylase therapy for MNGIE.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.24

Treatment of mitochondrial neurogastrointestinal encephalomyopathy with dialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.24

Definitive diagnosis of mitochondrial neurogastrointestinal encephalomyopathy by biochemical assays

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.24

Hematopoietic stem-cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.24

Correction of ADA-SCID by stem cell gene therapy combined with nonmyeloablative conditioning

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.24

Hematopoietic stem cell gene therapy with a lentiviral vector in X-linked adrenoleukodystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.24

Correction of X-linked chronic granulomatous disease by gene therapy, augmented by insertional activation of MDS1-EVI1, PRDM16 or SETBP1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.24

LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.24

Genomic instability and myelodysplasia with monosomy 7 consequent to EVI1 activation after gene therapy for chronic granulomatous disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.24

Recent advances in lentiviral vector development and applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.24

The genotoxic potential of retroviral vectors is strongly modulated by vector design and integration site selection in a mouse model of HSC gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.24

Transcription start regions in the human genome are favored targets for MLV integration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.24

A novel thymidine phosphorylase mutation in a Spanish MNGIE patient.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.24

Steps involved in immortalization and tumorigenesis in human B-lymphoblastoid cell lines transformed by Epstein-Barr virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.24

Functional analysis of gammaretroviral vector transduction by quantitative PCR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.24

Quantitation of cellular deoxynucleoside triphosphates

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.24

Origins of mitochondrial thymidine triphosphate: Dynamic relations to cytosolic pools

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.24

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.24

Infusion of platelets transiently reduces nucleoside overload in MNGIE

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21451581

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Differences in activities and substrate specificity of human and murine pyrimidine nucleoside phosphorylases: implications for chemotherapy with 5-fluoropyrimidines

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21451581

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1038/GT.2011.24

1 reference

13 September 2017

0 references

1 reference